The key to driving down costs, or at the very least making costs more predictable, is integrating pathways into the Oncology Care Model program, said John L. Fox, MD, MS, associate vice president of medical affairs at Priority Health.
The key to driving down costs, or at the very least making costs more predictable, is integrating pathways into the Oncology Care Model program, said John L. Fox, MD, MS, associate vice president of medical affairs at Priority Health.
Transcript (slightly modified)
Can we draw parallels between payer-driven clinical pathways and the Oncology Medical Home model?
Medicare's Oncology Care Model, which I’m not an expert on, I think has a potential to drive down the cost of healthcare without impacting patient outcomes. There are a number of ways that can happen. One is that the cost of care will become more predictable because the regimens that providers use will have a more predictable cost.
In our experience with our Oncology Medical Home Initiative, where we ask providers to develop pathways around high-volume conditions and not only pathways but preferred regimens, we very clearly showed that providers tended to choose the less costly regimens. So I think that integration of pathways into an oncology care model program is not only essential, but that’s what will help drive down costs, at least make costs more predictable.
But more importantly, I think the pathways have to include or embed advanced care planning. The trends for increasing costs of drugs don’t suggest that will drive down the costs of care simply by having pathways. But if those pathways include discussions of patient preferences and goals of care, then I think it increases the likelihood that will diminish the amount of chemotherapy we’ll give to patients at the end-of-life because they’ll have said, my goals can be obtained in ways other than chemotherapy.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More